Morgan Stanley’s Indivior Pharmaceuticals INDV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$107M Sell
3,505,817
-871,957
-20% -$28.8M 0.01% 1385
2025
Q4
$157M Sell
4,377,774
-1,245,479
-22% -$38M 0.01% 1088
2025
Q3
$136M Buy
5,623,253
+5,055,982
+891% +$106M 0.01% 1165
2025
Q2
$8.36M Sell
567,271
-145,912
-20% -$1.7M ﹤0.01% 3600
2025
Q1
$6.8M Sell
713,183
-2,830,909
-80% -$29.8M ﹤0.01% 3663
2024
Q4
$44.1M Sell
3,544,092
-1,675,252
-32% -$17.2M ﹤0.01% 1943
2024
Q3
$50.9M Buy
5,219,344
+5,075,758
+3,535% +$59.4M ﹤0.01% 1809
2024
Q2
$2.31M Sell
143,586
-54,665
-28% -$987K ﹤0.01% 4466
2024
Q1
$4.25M Buy
198,251
+186,425
+1,576% +$3.5M ﹤0.01% 4034
2023
Q4
$181K Buy
11,826
+6,083
+106% +$108K ﹤0.01% 5981
2023
Q3
$132K Buy
5,743
+3,899
+211% +$88.9K ﹤0.01% 5752
2023
Q2
$43.9K Buy
+1,844
New +$42.3K ﹤0.01% 6259

Other funds holding INDV